Keywords
Last Name
Institution

Peter Palese

TitlePROFESSOR & CHAIR
InstitutionMount Sinai
DepartmentMicrobiology
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentInfectious Diseases


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Krammer F, Palese P. Universal influenza virus vaccines: need for clinical trials. Nat Immunol. 2013 Dec 18; 15(1):3-5.
      View in: PubMed
    2. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun. 2013 Dec 10; 4:2854.
      View in: PubMed
    3. Heaton NS, Sachs D, Chen CJ, Hai R, Palese P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A. 2013 Dec 10; 110(50):20248-53.
      View in: PubMed
    4. Margine I, Palese P, Krammer F. Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System. J Vis Exp. 2013; (81).
      View in: PubMed
    5. Goff PH, Eggink D, Seibert CW, Hai R, Martínez-Gil L, Krammer F, Palese P. Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. PLoS One. 2013; 8(11):e79194.
      View in: PubMed
    6. Eggink D, Goff PH, Palese P. Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain. J Virol. 2014 Jan; 88(1):699-704.
      View in: PubMed
    7. Krammer F, Palese P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol. 2013 Oct; 3(5):521-30.
      View in: PubMed
    8. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013 Aug 14; 5(198):198ra107.
      View in: PubMed
    9. Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J Virol. 2013 Oct; 87(19):10435-46.
      View in: PubMed
    10. Martinez-Gil L, Alamares-Sapuay JG, Ramana Reddy MV, Goff PH, Premkumar Reddy E, Palese P. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis. Antiviral Res. 2013 Oct; 100(1):29-37.
      View in: PubMed
    11. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol. 2013 Jul; 87(14):8235-40.
      View in: PubMed
    12. Seibert CW, Rahmat S, Krause JC, Eggink D, Albrecht RA, Goff PH, Krammer F, Duty JA, Bouvier NM, García-Sastre A, Palese P. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J Virol. 2013 Jul; 87(14):7793-804.
      View in: PubMed
    13. Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol. 2013 Aug; 87(15):8272-81.
      View in: PubMed
    14. Chou YY, Heaton NS, Gao Q, Palese P, Singer RH, Singer R, Lionnet T. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog. 2013; 9(5):e1003358.
      View in: PubMed
    15. Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol. 2013 Jun; 87(12):6542-50.
      View in: PubMed
    16. Alamares-Sapuay JG, Martinez-Gil L, Stertz S, Miller MS, Shaw ML, Palese P. Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus. J Virol. 2013 May; 87(10):6020-6.
      View in: PubMed
    17. Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, Palucka K, García-Sastre A, Palese P, Treanor JJ, Krammer F. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol. 2013 Apr; 87(8):4728-37.
      View in: PubMed
    18. Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, Katz JM, Kiselev OI, Klenk HD, Kobinger G, Liu J, Liu X, Lowen A, Mettenleiter TC, Osterhaus AD, Palese P, Peiris JS, Perez DR, Richt JA, Schultz-Cherry S, Steel J, Subbarao K, Swayne DE, Takimoto T, Tashiro M, Taubenberger JK, Thomas PG, Tripp RA, Tumpey TM, Webby RJ, Webster RG. Transmission studies resume for avian flu. Science. 2013 Feb 1; 339(6119):520-1.
      View in: PubMed
    19. Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med. 2013; 64:189-202.
      View in: PubMed
    20. Martínez-Gil L, Goff PH, Hai R, García-Sastre A, Shaw ML, Palese P. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol. 2013 Feb; 87(3):1290-300.
      View in: PubMed
    21. Martínez-Gil L, Ayllon J, Ortigoza MB, García-Sastre A, Shaw ML, Palese P. Identification of small molecules with type I interferon inducing properties by high-throughput screening. PLoS One. 2012; 7(11):e49049.
      View in: PubMed
    22. Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J Infect Dis. 2013 Jan 1; 207(1):98-105.
      View in: PubMed
    23. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, Lee JH, Dillon MA, O'Neil RE, Faynboym AM, Horowitz M, Horowitz L, Ward AB, Palese P, Webby R, Lerner RA, Bhatt RR, Wilson IA. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature. 2012 Sep 27; 489(7417):526-32.
      View in: PubMed
    24. Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One. 2012; 7(8):e43603.
      View in: PubMed
    25. Goff PH, Gao Q, Palese P. A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes. J Virol. 2012 Oct; 86(19):10852-6.
      View in: PubMed
    26. Krammer F, Pica N, Hai R, Tan GS, Palese P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. J Virol. 2012 Oct; 86(19):10302-7.
      View in: PubMed
    27. Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J Virol. 2012 Oct; 86(19):10293-301.
      View in: PubMed
    28. Leyva-Grado VH, Mubareka S, Krammer F, Cárdenas WB, Palese P. Influenza virus infection in guinea pigs raised as livestock, Ecuador. Emerg Infect Dis. 2012 Jul; 18(7):1135-8.
      View in: PubMed
    29. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol. 2012 Aug; 86(16):8359-66.
      View in: PubMed
    30. Chou YY, Vafabakhsh R, Doganay S, Gao Q, Ha T, Palese P. One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A. 2012 Jun 5; 109(23):9101-6.
      View in: PubMed
    31. Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P, Ayllon J, Palese P, Shaw ML. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog. 2012; 8(4):e1002668.
      View in: PubMed
    32. Gao Q, Chou YY, Doganay S, Vafabakhsh R, Ha T, Palese P. The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging. J Virol. 2012 Jul; 86(13):7043-51.
      View in: PubMed
    33. Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol. 2012 Jun; 86(11):6179-88.
      View in: PubMed
    34. Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol. 2012 May; 86(10):5782-90.
      View in: PubMed
    35. Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol. 2012 May; 86(10):5774-81.
      View in: PubMed
    36. Zamarin D, Palese P. Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol. 2012 Mar; 7(3):347-67.
      View in: PubMed
    37. Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science. 2012 Mar 23; 335(6075):1463.
      View in: PubMed
    38. Seibert CW, Rahmat S, Krammer F, Palese P, Bouvier NM. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. J Virol. 2012 May; 86(9):5386-9.
      View in: PubMed
    39. Pica N, Chou YY, Bouvier NM, Palese P. Transmission of influenza B viruses in the guinea pig. J Virol. 2012 Apr; 86(8):4279-87.
      View in: PubMed
    40. Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2573-8.
      View in: PubMed
    41. Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, Katz J, Klenk HD, Kobinger G, Liu J, Liu X, Lowen A, Mettenleiter TC, Osterhaus AD, Palese P, Peiris JS, Perez DR, Richt JA, Schultz-Cherry S, Steel J, Subbarao K, Swayne DE, Takimoto T, Tashiro M, Taubenberger JK, Thomas PG, Tripp RA, Tumpey TM, Webby RJ, Webster RG. Pause on avian flu transmission research. Science. 2012 Jan 27; 335(6067):400-1.
      View in: PubMed
    42. Palese P, Wang TT. H5N1 influenza viruses: facts, not fear. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2211-3.
      View in: PubMed
    43. Palese P. Don't censor life-saving science. Nature. 2012 Jan 12; 481(7380):115.
      View in: PubMed
    44. Varga ZT, Palese P. The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence. 2011 Nov-Dec; 2(6):542-6.
      View in: PubMed
    45. Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, García-Sastre A, Lowen AC, Palese P, Steel J. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J Virol. 2011 Dec; 85(23):12825-9.
      View in: PubMed
    46. Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol. 2011 Nov; 85(21):11235-41.
      View in: PubMed
    47. Palese P, Wang TT. Why do influenza virus subtypes die out? A hypothesis. MBio. 2011; 2(5).
      View in: PubMed
    48. Wang TT, Palese P. Biochemistry. Catching a moving target. Science. 2011 Aug 12; 333(6044):834-5.
      View in: PubMed
    49. Varga ZT, Ramos I, Hai R, Schmolke M, García-Sastre A, Fernandez-Sesma A, Palese P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 2011 Jun; 7(6):e1002067.
      View in: PubMed
    50. Hai R, García-Sastre A, Swayne DE, Palese P. A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains. J Virol. 2011 Jul; 85(14):6832-43.
      View in: PubMed
    51. Mansour M, Palese P, Zamarin D. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. J Virol. 2011 Jun; 85(12):6015-23.
      View in: PubMed
    52. Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A. 2011 Apr 5; 108(14):5777-82.
      View in: PubMed
    53. Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol. 2011 Mar; 85(6):2480-91.
      View in: PubMed
    54. Maamary J, Array F, Gao Q, García-Sastre A, Steinman RM, Palese P, Nchinda G. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice. J Virol. 2011 Mar; 85(5):2235-46.
      View in: PubMed
    55. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol. 2011 Jan; 85(2):652-62.
      View in: PubMed
    56. Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol. 2011 Feb; 85(3):1400-2.
      View in: PubMed
    57. Li P, Chen CH, Li S, Givi B, Yu Z, Zamarin D, Palese P, Fong Y, Wong RJ. Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Head Neck. 2011 Oct; 33(10):1394-9.
      View in: PubMed
    58. Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A. 2010 Nov 2; 107(44):18979-84.
      View in: PubMed
    59. Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, García-Sastre A, Staeheli P, Palese P. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol. 2010 Nov; 84(21):11219-26.
      View in: PubMed
    60. Kashyap AK, Steel J, Rubrum A, Estelles A, Briante R, Ilyushina NA, Xu L, Swale RE, Faynboym AM, Foreman PK, Horowitz M, Horowitz L, Webby R, Palese P, Lerner RA, Bhatt RR. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog. 2010; 6(7):e1000990.
      View in: PubMed
    61. Medina RA, Manicassamy B, Stertz S, Seibert CW, Hai R, Belshe RB, Frey SE, Basler CF, Palese P, García-Sastre A. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun. 2010; 1:28.
      View in: PubMed
    62. Gao Q, Lowen AC, Wang TT, Palese P. A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins. J Virol. 2010 Aug; 84(16):8062-71.
      View in: PubMed
    63. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, García-Sastre A, Palese P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio. 2010 Apr; 1(1).
      View in: PubMed
    64. Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 2010 Feb; 6(2):e1000796.
      View in: PubMed
    65. Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, Pearce MB, García-Sastre A, Tumpey TM, Palese P. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol. 2010 May; 84(9):4442-50.
      View in: PubMed
    66. König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. Human host factors required for influenza virus replication. Nature. 2010 Feb 11; 463(7282):813-7.
      View in: PubMed
    67. Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 2010 Jan; 6(1):e1000745.
      View in: PubMed
    68. Steel J, Staeheli P, Mubareka S, García-Sastre A, Palese P, Lowen AC. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol. 2010 Jan; 84(1):21-6.
      View in: PubMed
    69. Martínez-Sobrido L, Cadagan R, Steel J, Basler CF, Palese P, Moran TM, García-Sastre A. Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol. 2010 Feb; 84(4):2157-63.
      View in: PubMed
    70. Wong J, Schulman A, Kelly K, Zamarin D, Palese P, Fong Y. Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus. J Gastrointest Surg. 2010 Jan; 14(1):7-14.
      View in: PubMed
    71. Gao Q, Palese P. Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci U S A. 2009 Sep 15; 106(37):15891-6.
      View in: PubMed
    72. Lowen A, Palese P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: a hypothesis. PLoS Curr. 2009; 1:RRN1002.
      View in: PubMed
    73. Wang TT, Palese P. Unraveling the mystery of swine influenza virus. Cell. 2009 Jun 12; 137(6):983-5.
      View in: PubMed
    74. Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 2009 Jun 8; 27(28):3766-74.
      View in: PubMed
    75. Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis. 2009 Mar 15; 199(6):858-65.
      View in: PubMed
    76. Wang TT, Palese P. Universal epitopes of influenza virus hemagglutinins? Nat Struct Mol Biol. 2009 Mar; 16(3):233-4.
      View in: PubMed
    77. Kulkarni S, Volchkova V, Basler CF, Palese P, Volchkov VE, Shaw ML. Nipah virus edits its P gene at high frequency to express the V and W proteins. J Virol. 2009 Apr; 83(8):3982-7.
      View in: PubMed
    78. Zamarin D, Martínez-Sobrido L, Kelly K, Mansour M, Sheng G, Vigil A, García-Sastre A, Palese P, Fong Y. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther. 2009 Apr; 17(4):697-706.
      View in: PubMed
    79. Lowen AC, Steel J, Mubareka S, Carnero E, García-Sastre A, Palese P. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol. 2009 Apr; 83(7):2803-18.
      View in: PubMed
    80. Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D. Unsung hero Robert C. Gallo. Science. 2009 Jan 9; 323(5911):206-7.
      View in: PubMed
    81. Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 2009 Jan; 5(1):e1000252.
      View in: PubMed
    82. Kopecky-Bromberg SA, Palese P. Recombinant vectors as influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:243-67.
      View in: PubMed
    83. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet J. 2009 Jan; 41(1):87-92.
      View in: PubMed
    84. Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2009 Feb; 83(4):1742-53.
      View in: PubMed
    85. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008 Sep 12; 26 Suppl 4:D49-53.
      View in: PubMed
    86. Hai R, Martínez-Sobrido L, Fraser KA, Ayllon J, García-Sastre A, Palese P. Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol. 2008 Nov; 82(21):10580-90.
      View in: PubMed
    87. Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J Virol. 2008 Oct; 82(20):10052-8.
      View in: PubMed
    88. Hoffmann HH, Palese P, Shaw ML. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res. 2008 Nov; 80(2):124-34.
      View in: PubMed
    89. Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. Cellular proteins in influenza virus particles. PLoS Pathog. 2008 Jun; 4(6):e1000085.
      View in: PubMed
    90. Gao Q, Brydon EW, Palese P. A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J Virol. 2008 Jul; 82(13):6419-26.
      View in: PubMed
    91. Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, Horowitz L, Palese P, Bhatt RR, Lerner RA. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A. 2008 Apr 22; 105(16):5986-91.
      View in: PubMed
    92. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol. 2008 Jun; 82(11):5650-2.
      View in: PubMed
    93. Pappas C, Aguilar PV, Basler CF, Solórzano A, Zeng H, Perrone LA, Palese P, García-Sastre A, Katz JM, Tumpey TM. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A. 2008 Feb 26; 105(8):3064-9.
      View in: PubMed
    94. Gao Q, Park MS, Palese P. Expression of transgenes from newcastle disease virus with a segmented genome. J Virol. 2008 Mar; 82(6):2692-8.
      View in: PubMed
    95. Mubareka S, Palese P. Human genes and influenza. J Infect Dis. 2008 Jan 1; 197(1):1-3.
      View in: PubMed
    96. Marsh GA, Rabadán R, Levine AJ, Palese P. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol. 2008 Mar; 82(5):2295-304.
      View in: PubMed
    97. Steel J, Burmakina SV, Thomas C, Spackman E, García-Sastre A, Swayne DE, Palese P. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine. 2008 Jan 24; 26(4):522-31.
      View in: PubMed
    98. Lowen AC, Palese P. Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets. 2007 Dec; 7(4):318-28.
      View in: PubMed
    99. Ahmed R, Oldstone MB, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol. 2007 Nov; 8(11):1188-93.
      View in: PubMed
    100. Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007 Oct 19; 3(10):1470-6.
      View in: PubMed
    101. Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe. 2007 Oct 11; 2(4):207-9.
      View in: PubMed
    102. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007 Oct 5; 3(10):1414-21.
      View in: PubMed
    103. Marsh GA, Hatami R, Palese P. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J Virol. 2007 Sep; 81(18):9727-36.
      View in: PubMed
    104. Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol. 2007 Sep; 81(18):9812-24.
      View in: PubMed
    105. Legastelois I, Garcia-Sastre A, Palese P, Tumpey TM, Maines TR, Katz JM, Vogel FR, Moste C. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Viruses. 2007 May; 1(3):95-104.
      View in: PubMed
    106. He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, Okenu D, Bandea C, Ananaba GA, Black CM, Igietseme JU. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology. 2007 Sep; 122(1):28-37.
      View in: PubMed
    107. Glaser L, Conenello G, Paulson J, Palese P. Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res. 2007 Jun; 126(1-2):9-18.
      View in: PubMed
    108. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solórzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, García-Sastre A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007 Feb 2; 315(5812):655-9.
      View in: PubMed
    109. Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol. 2007 Jan; 81(2):548-57.
      View in: PubMed
    110. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, García-Sastre A, Swayne DE, Katze MG. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006 Oct 5; 443(7111):578-81.
      View in: PubMed
    111. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol. 2006 Aug; 80(16):7976-83.
      View in: PubMed
    112. Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A. 2006 Jun 27; 103(26):9988-92.
      View in: PubMed
    113. Park MS, Steel J, García-Sastre A, Swayne D, Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A. 2006 May 23; 103(21):8203-8.
      View in: PubMed
    114. Glaser L, Zamarin D, Acland HM, Spackman E, Palese P, García-Sastre A, Tewari D. Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America. Glycoconj J. 2006 Feb; 23(1-2):93-9.
      View in: PubMed
    115. Palese P, Tumpey TM, Garcia-Sastre A. What can we learn from reconstructing the extinct 1918 pandemic influenza virus? Immunity. 2006 Feb; 24(2):121-4.
      View in: PubMed
    116. Palese P. Making better influenza virus vaccines? Emerg Infect Dis. 2006 Jan; 12(1):61-5.
      View in: PubMed
    117. Kopecky-Bromberg SA, Martinez-Sobrido L, Palese P. 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. J Virol. 2006 Jan; 80(2):785-93.
      View in: PubMed
    118. Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solórzano A, Van Rooijen N, Katz JM, Basler CF. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005 Dec; 79(23):14933-44.
      View in: PubMed
    119. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol. 2006 Feb 3; 355(5):1143-55.
      View in: PubMed
    120. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, García-Sastre A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005 Oct 7; 310(5745):77-80.
      View in: PubMed
    121. Zamarin D, García-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 2005 Sep; 1(1):e4.
      View in: PubMed
    122. Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, Basler CF, Taubenberger JK, Palese P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol. 2005 Sep; 79(17):11533-6.
      View in: PubMed
    123. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol. 2005 Jul; 79(13):8431-9.
      View in: PubMed
    124. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol. 2005 May; 79(10):6078-88.
      View in: PubMed
    125. Efferson CL, Kawano K, Tsuda N, Palese P, García-Sastre A, Ioannides CG. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15. Anticancer Res. 2005 Mar-Apr; 25(2A):715-24.
      View in: PubMed
    126. Cros JF, García-Sastre A, Palese P. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic. 2005 Mar; 6(3):205-13.
      View in: PubMed
    127. Basler CF, García-Sastre A, Palese P. A novel paramyxovirus? Emerg Infect Dis. 2005 Jan; 11(1):108-12.
      View in: PubMed
    128. Palese P. Influenza: old and new threats. Nat Med. 2004 Dec; 10(12 Suppl):S82-7.
      View in: PubMed
    129. Nakaya Y, Nakaya T, Park MS, Cros J, Imanishi J, Palese P, García-Sastre A. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors. J Virol. 2004 Sep; 78(17):9366-75.
      View in: PubMed
    130. Shaw ML, García-Sastre A, Palese P, Basler CF. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol. 2004 Jun; 78(11):5633-41.
      View in: PubMed
    131. Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A. 2004 Mar 2; 101(9):3166-71.
      View in: PubMed
    132. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science. 2004 Mar 19; 303(5665):1866-70.
      View in: PubMed
    133. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, García-Sastre A, Ball LA, Palese P, Ding SW. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1350-5.
      View in: PubMed
    134. González-Aseguinolaza G, Nakaya Y, Molano A, Dy E, Esteban M, Rodríguez D, Rodríguez JR, Palese P, García-Sastre A, Nussenzweig RS. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii. J Virol. 2003 Nov; 77(21):11859-66.
      View in: PubMed
    135. Flandorfer A, García-Sastre A, Basler CF, Palese P. Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. J Virol. 2003 Sep; 77(17):9116-23.
      View in: PubMed
    136. Park MS, García-Sastre A, Cros JF, Basler CF, Palese P. Newcastle disease virus V protein is a determinant of host range restriction. J Virol. 2003 Sep; 77(17):9522-32.
      View in: PubMed
    137. Cros JF, Palese P. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res. 2003 Sep; 95(1-2):3-12.
      View in: PubMed
    138. Efferson CL, Schickli J, Ko BK, Kawano K, Mouzi S, Palese P, García-Sastre A, Ioannides CG. Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene. J Virol. 2003 Jul; 77(13):7411-24.
      View in: PubMed
    139. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 2003 Jul; 77(14):7945-56.
      View in: PubMed
    140. Swayne DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastre A. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis. 2003; 47(3 Suppl):1047-50.
      View in: PubMed
    141. Park MS, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, García-Sastre A, Basler CF. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol. 2003 Jan; 77(2):1501-11.
      View in: PubMed
    142. Wang X, Basler CF, Williams BR, Silverman RH, Palese P, García-Sastre A. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol. 2002 Dec; 76(24):12951-62.
      View in: PubMed
    143. Tumpey TM, García-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, Palese P, Basler CF. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13849-54.
      View in: PubMed
    144. Palese P, Basler CF, García-Sastre A. The makings of a killer. Nat Med. 2002 Sep; 8(9):927-8.
      View in: PubMed
    145. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, García-Sastre A. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10736-41.
      View in: PubMed
    146. Palese P, García-Sastre A. Influenza vaccines: present and future. J Clin Invest. 2002 Jul; 110(1):9-13.
      View in: PubMed
    147. Palese P, García-Sastre A. New directions in vaccine research. J Clin Invest. 2002 Jun; 109(12):1517-8.
      View in: PubMed
    148. Mora R, Rodriguez-Boulan E, Palese P, García-Sastre A. Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol. 2002 Apr; 76(7):3544-53.
      View in: PubMed
    149. Salvatore M, Basler CF, Parisien JP, Horvath CM, Bourmakina S, Zheng H, Muster T, Palese P, García-Sastre A. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol. 2002 Feb; 76(3):1206-12.
      View in: PubMed
    150. Schickli JH, Flandorfer A, Nakaya T, Martinez-Sobrido L, García-Sastre A, Palese P. Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29; 356(1416):1965-73.
      View in: PubMed
    151. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med. 2001 Dec; 7(12):1306-12.
      View in: PubMed
    152. Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A, Villar E, García-Sastre A, Palese P. Recombinant Newcastle disease virus as a vaccine vector. J Virol. 2001 Dec; 75(23):11868-73.
      View in: PubMed
    153. Bergmann M, Romirer I, Sachet M, Fleischhacker R, García-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R, Muster T. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res. 2001 Nov 15; 61(22):8188-93.
      View in: PubMed
    154. Paragas J, Talon J, O'Neill RE, Anderson DK, García-Sastre A, Palese P. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. J Virol. 2001 Aug; 75(16):7375-83.
      View in: PubMed
    155. Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, Salvatore M, Perdue ML, Swayne DE, García-Sastre A, Palese P, Taubenberger JK. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2746-51.
      View in: PubMed
    156. Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K. Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol. 2001 Feb; 75(4):1899-908.
      View in: PubMed
    157. Zheng H, Palese P, García-Sastre A. Antitumor properties of influenza virus vectors. Cancer Res. 2000 Dec 15; 60(24):6972-6.
      View in: PubMed
    158. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, García-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 2000 Dec; 74(24):11566-73.
      View in: PubMed
    159. Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, García-Sastre A, Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12289-94.
      View in: PubMed
    160. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol. 2000 Sep; 74(17):7989-96.
      View in: PubMed
    161. Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol. 2000 Jul; 74(13):6203-6.
      View in: PubMed
    162. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, García-Sastre A, Palese P. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4309-14.
      View in: PubMed
    163. Gilleland HE, Gilleland LB, Staczek J, Harty RN, García-Sastre A, Palese P, Brennan FR, Hamilton WD, Bendahmane M, Beachy RN. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. FEMS Immunol Med Microbiol. 2000 Apr; 27(4):291-7.
      View in: PubMed
    164. Solorzano A, Zheng H, Fodor E, Brownlee GG, Palese P, García-Sastre A. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice. J Gen Virol. 2000 Mar; 81(Pt 3):737-42.
      View in: PubMed
    165. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, García-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999 Nov; 73(11):9679-82.
      View in: PubMed
    166. Basler CF, García-Sastre A, Palese P. Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses. J Virol. 1999 Oct; 73(10):8095-103.
      View in: PubMed
    167. Zheng H, Lee HA, Palese P, García-Sastre A. Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. J Virol. 1999 Jun; 73(6):5240-3.
      View in: PubMed
    168. Harty RN, Paragas J, Sudol M, Palese P. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol. 1999 Apr; 73(4):2921-9.
      View in: PubMed
    169. Craven RC, Harty RN, Paragas J, Palese P, Wills JW. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol. 1999 Apr; 73(4):3359-65.
      View in: PubMed
    170. Gonzalo RM, Rodríguez D, García-Sastre A, Rodríguez JR, Palese P, Esteban M. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants. Vaccine. 1999 Feb 26; 17(7-8):887-92.
      View in: PubMed
    171. Palese P, Muster T, Zheng H, O'Neill R, Garcia-Sastre A. Learning from our foes: a novel vaccine concept for influenza virus. Arch Virol Suppl. 1999; 15:131-8.
      View in: PubMed
    172. García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1998 Dec 20; 252(2):324-30.
      View in: PubMed
    173. García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism. J Virol. 1998 Nov; 72(11):8550-8.
      View in: PubMed
    174. Palese P. RNA virus vectors: where are we and where do we need to go? Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):12750-2.
      View in: PubMed
    175. Restifo NP, Surman DR, Zheng H, Palese P, Rosenberg SA, García-Sastre A. Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer. Virology. 1998 Sep 15; 249(1):89-97.
      View in: PubMed
    176. Wolff T, O'Neill RE, Palese P. NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol. 1998 Sep; 72(9):7170-80.
      View in: PubMed
    177. Fodor E, Palese P, Brownlee GG, García-Sastre A. Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol. 1998 Aug; 72(8):6283-90.
      View in: PubMed
    178. Staczek J, Gilleland HE, Gilleland LB, Harty RN, García-Sastre A, Engelhardt OG, Palese P. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun. 1998 Aug; 66(8):3990-4.
      View in: PubMed
    179. Miyahira Y, García-Sastre A, Rodriguez D, Rodriguez JR, Murata K, Tsuji M, Palese P, Esteban M, Zavala F, Nussenzweig RS. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A. 1998 Mar 31; 95(7):3954-9.
      View in: PubMed
    180. O'Neill RE, Talon J, Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 1998 Jan 2; 17(1):288-96.
      View in: PubMed
    181. Palese P, Zavala F, Muster T, Nussenzweig RS, García-Sastre A. Development of novel influenza virus vaccines and vectors. J Infect Dis. 1997 Aug; 176 Suppl 1:S45-9.
      View in: PubMed
    182. Wang P, Palese P, O'Neill RE. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol. 1997 Mar; 71(3):1850-6.
      View in: PubMed
    183. Gilleland HE, Gilleland LB, Staczek J, Harty RN, Garcia-Sastre A, Engelhardt OG, Palese P. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa. Behring Inst Mitt. 1997 Feb; (98):291-301.
      View in: PubMed
    184. Palese P, Zheng H, Engelhardt OG, Pleschka S, García-Sastre A. Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11354-8.
      View in: PubMed
    185. Palese P, Roizman B. Genetic engineering of viruses and of virus vectors: a preface. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11287.
      View in: PubMed
    186. Murata K, García-Sastre A, Tsuji M, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Palese P, Esteban M, Zavala F. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol. 1996 Oct 10; 173(1):96-107.
      View in: PubMed
    187. Wolff T, O'Neill RE, Palese P. Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol. 1996 Aug; 70(8):5363-72.
      View in: PubMed
    188. Pleschka S, Jaskunas R, Engelhardt OG, Zürcher T, Palese P, García-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol. 1996 Jun; 70(6):4188-92.
      View in: PubMed
    189. Zheng H, Palese P, García-Sastre A. Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. Virology. 1996 Mar 1; 217(1):242-51.
      View in: PubMed
    190. Harty RN, Palese P. Measles virus phosphoprotein (P) requires the NH2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself. J Gen Virol. 1995 Nov; 76 ( Pt 11):2863-7.
      View in: PubMed
    191. Muster T, Ferko B, Klima A, Purtscher M, Trkola A, Schulz P, Grassauer A, Engelhardt OG, García-Sástre A, Palese P, et al. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol. 1995 Nov; 69(11):6678-86.
      View in: PubMed
    192. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem. 1995 Sep 29; 270(39):22701-4.
      View in: PubMed
    193. Harty RN, Palese P. Mutations within noncoding terminal sequences of model RNAs of Sendai virus: influence on reporter gene expression. J Virol. 1995 Aug; 69(8):5128-31.
      View in: PubMed
    194. García-Sastre A, Palese P. The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes. Virus Res. 1995 Jun; 37(1):37-47.
      View in: PubMed
    195. García-Sastre A, Palese P. Influenza virus vectors. Biologicals. 1995 Jun; 23(2):171-8.
      View in: PubMed
    196. Palese P. Genetic engineering of infectious negative-strand RNA viruses. Trends Microbiol. 1995 Apr; 3(4):123-5.
      View in: PubMed
    197. Barclay WS, Palese P. Influenza B viruses with site-specific mutations introduced into the HA gene. J Virol. 1995 Feb; 69(2):1275-9.
      View in: PubMed
    198. O'Neill RE, Palese P. NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology. 1995 Jan 10; 206(1):116-25.
      View in: PubMed
    199. Isobe H, Moran T, Li S, Young A, Nathenson S, Palese P, Bona C. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant. J Exp Med. 1995 Jan 1; 181(1):203-13.
      View in: PubMed
    200. García-Sastre A, Muster T, Barclay WS, Percy N, Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J Virol. 1994 Oct; 68(10):6254-61.
      View in: PubMed
    201. Carabellese F, Sacco MP, Amerio L, Buzzerio R, Palese P. [Some notes on psychopathological origins of maladjustment of young conscripts in national service: a methodological contribution in the diagnosis of personality disorders]. Minerva Psichiatr. 1994 Sep; 35(3):147-54.
      View in: PubMed
    202. Zurcher T, Luo G, Palese P. Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation. J Virol. 1994 Sep; 68(9):5748-54.
      View in: PubMed
    203. Percy N, Barclay WS, García-Sastre A, Palese P. Expression of a foreign protein by influenza A virus. J Virol. 1994 Jul; 68(7):4486-92.
      View in: PubMed
    204. Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, Katinger H. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol. 1994 Jun; 68(6):4031-4.
      View in: PubMed
    205. O'Neill RE, Palese P. Cis-acting signals and trans-acting factors involved in influenza virus RNA synthesis. Infect Agents Dis. 1994 Apr-Jun; 3(2-3):77-84.
      View in: PubMed
    206. Li X, Palese P. Characterization of the polyadenylation signal of influenza virus RNA. J Virol. 1994 Feb; 68(2):1245-9.
      View in: PubMed
    207. García-Sastre A, Percy N, Barclay W, Palese P. Introduction of foreign sequences into the genome of influenza A virus. Dev Biol Stand. 1994; 82:237-46.
      View in: PubMed
    208. Li S, Polonis V, Isobe H, Zaghouani H, Guinea R, Moran T, Bona C, Palese P. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol. 1993 Nov; 67(11):6659-66.
      View in: PubMed
    209. Li S, Schulman J, Itamura S, Palese P. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol. 1993 Nov; 67(11):6667-73.
      View in: PubMed
    210. Luo G, Chung J, Palese P. Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions. Virus Res. 1993 Sep; 29(3):321.
      View in: PubMed
    211. Luo G, Chung J, Palese P. Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions. Virus Res. 1993 Aug; 29(2):141-53.
      View in: PubMed
    212. Li S, Rodrigues M, Rodriguez D, Rodriguez JR, Esteban M, Palese P, Nussenzweig RS, Zavala F. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A. 1993 Jun 1; 90(11):5214-8.
      View in: PubMed
    213. Piccone ME, Fernandez-Sesma A, Palese P. Mutational analysis of the influenza virus vRNA promoter. Virus Res. 1993 May; 28(2):99-112.
      View in: PubMed
    214. García-Sastre A, Palese P. Genetic manipulation of negative-strand RNA virus genomes. Annu Rev Microbiol. 1993; 47:765-90.
      View in: PubMed
    215. Bergmann M, García-Sastre A, Palese P. Transfection-mediated recombination of influenza A virus. J Virol. 1992 Dec; 66(12):7576-80.
      View in: PubMed
    216. Luo G, Bergmann M, Garcia-Sastre A, Palese P. Mechanism of attenuation of a chimeric influenza A/B transfectant virus. J Virol. 1992 Aug; 66(8):4679-85.
      View in: PubMed
    217. Li X, Palese P. Mutational analysis of the promoter required for influenza virus virion RNA synthesis. J Virol. 1992 Jul; 66(7):4331-8.
      View in: PubMed
    218. Klotz FW, Orlandi PA, Reuter G, Cohen SJ, Haynes JD, Schauer R, Howard RJ, Palese P, Miller LH. Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol. 1992 Mar; 51(1):49-54.
      View in: PubMed
    219. Luo G, Palese P. Genetic analysis of influenza virus. Curr Opin Genet Dev. 1992 Feb; 2(1):77-81.
      View in: PubMed
    220. Li SQ, Schulman JL, Moran T, Bona C, Palese P. Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol. 1992 Jan; 66(1):399-404.
      View in: PubMed
    221. Enami M, Sharma G, Benham C, Palese P. An influenza virus containing nine different RNA segments. Virology. 1991 Nov; 185(1):291-8.
      View in: PubMed
    222. Muster T, Subbarao EK, Enami M, Murphy BR, Palese P. An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. Proc Natl Acad Sci U S A. 1991 Jun 15; 88(12):5177-81.
      View in: PubMed
    223. Luo GX, Luytjes W, Enami M, Palese P. The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol. 1991 Jun; 65(6):2861-7.
      View in: PubMed
    224. Fitch WM, Leiter JM, Li XQ, Palese P. Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A. 1991 May 15; 88(10):4270-4.
      View in: PubMed
    225. Lin DA, Roychoudhury S, Palese P, Clay WC, Fuller FJ. Evolutionary relatedness of the predicted gene product of RNA segment 2 of the tick-borne Dhori virus and the PB1 polymerase gene of influenza viruses. Virology. 1991 May; 182(1):1-7.
      View in: PubMed
    226. Enami M, Palese P. High-efficiency formation of influenza virus transfectants. J Virol. 1991 May; 65(5):2711-3.
      View in: PubMed
    227. Huang TS, Palese P, Krystal M. Determination of influenza virus proteins required for genome replication. J Virol. 1990 Nov; 64(11):5669-73.
      View in: PubMed
    228. Leiter JM, Agrawal S, Palese P, Zamecnik PC. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci U S A. 1990 May; 87(9):3430-4.
      View in: PubMed
    229. Enami M, Luytjes W, Krystal M, Palese P. Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A. 1990 May; 87(10):3802-5.
      View in: PubMed
    230. Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 1989 Dec 22; 59(6):1107-13.
      View in: PubMed
    231. Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. J Virol. 1989 Dec; 63(12):5142-52.
      View in: PubMed
    232. Leiter JM, Krystal M, Palese P. Expression of antisense RNA fails to inhibit influenza virus replication. Virus Res. 1989 Oct; 14(2):141-59.
      View in: PubMed
    233. Yamashita M, Krystal M, Palese P. Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology. 1989 Aug; 171(2):458-66.
      View in: PubMed
    234. Vlasak R, Muster T, Lauro AM, Powers JC, Palese P. Influenza C virus esterase: analysis of catalytic site, inhibition, and possible function. J Virol. 1989 May; 63(5):2056-62.
      View in: PubMed
    235. Li RA, Palese P, Krystal M. Complementation and analysis of an NP mutant of influenza virus. Virus Res. 1989 Feb; 12(2):97-111.
      View in: PubMed
    236. Vlasak R, Luytjes W, Leider J, Spaan W, Palese P. The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol. 1988 Dec; 62(12):4686-90.
      View in: PubMed
    237. Graves PN, Grabowski GA, Eisner R, Palese P, Smith FI. Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient. DNA. 1988 Oct; 7(8):521-8.
      View in: PubMed
    238. Smith FI, Latham TE, Ferrier JA, Palese P. Novel method of detecting single base substitutions in RNA molecules by differential melting behavior in solution. Genomics. 1988 Oct; 3(3):217-23.
      View in: PubMed
    239. Yamashita M, Krystal M, Palese P. Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA. J Virol. 1988 Sep; 62(9):3348-55.
      View in: PubMed
    240. Leider JM, Palese P, Smith FI. Determination of the mutation rate of a retrovirus. J Virol. 1988 Sep; 62(9):3084-91.
      View in: PubMed
    241. Greenspan D, Palese P, Krystal M. Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol. 1988 Aug; 62(8):3020-6.
      View in: PubMed
    242. Vlasak R, Luytjes W, Spaan W, Palese P. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A. 1988 Jun; 85(12):4526-9.
      View in: PubMed
    243. Yamashita M, Krystal M, Fitch WM, Palese P. Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology. 1988 Mar; 163(1):112-22.
      View in: PubMed
    244. Hsu MT, Parvin JD, Gupta S, Krystal M, Palese P. Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A. 1987 Nov; 84(22):8140-4.
      View in: PubMed
    245. Palese P, Webster R. Germ of an idea. Nature. 1987 Oct 8-14; 329(6139):480.
      View in: PubMed
    246. Vlasak R, Krystal M, Nacht M, Palese P. The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities. Virology. 1987 Oct; 160(2):419-25.
      View in: PubMed
    247. Smith GL, Levin JZ, Palese P, Moss B. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology. 1987 Oct; 160(2):336-45.
      View in: PubMed
    248. Norton GP, Tanaka T, Tobita K, Nakada S, Buonagurio DA, Greenspan D, Krystal M, Palese P. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology. 1987 Feb; 156(2):204-13.
      View in: PubMed
    249. Graves PN, Grabowski GA, Ludman MD, Palese P, Smith FI. Human acid beta-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts. Am J Hum Genet. 1986 Dec; 39(6):763-74.
      View in: PubMed
    250. Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol. 1986 Aug; 59(2):377-83.
      View in: PubMed
    251. Buonagurio DA, Nakada S, Fitch WM, Palese P. Epidemiology of influenza C virus in man: multiple evolutionary lineages and low rate of change. Virology. 1986 Aug; 153(1):12-21.
      View in: PubMed
    252. Buonagurio DA, Nakada S, Parvin JD, Krystal M, Palese P, Fitch WM. Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science. 1986 May 23; 232(4753):980-2.
      View in: PubMed
    253. Nakada S, Graves PN, Palese P. The influenza C virus NS gene: evidence for a spliced mRNA and a second NS gene product (NS2 protein). Virus Res. 1986 May; 4(3):263-73.
      View in: PubMed
    254. Smith FI, Parvin JD, Palese P. Detection of single base substitutions in influenza virus RNA molecules by denaturing gradient gel electrophoresis of RNA-RNA or DNA-RNA heteroduplexes. Virology. 1986 Apr 15; 150(1):55-64.
      View in: PubMed
    255. Krystal M, Li R, Lyles D, Pavlakis G, Palese P. Expression of the three influenza virus polymerase proteins in a single cell allows growth complementation of viral mutants. Proc Natl Acad Sci U S A. 1986 Apr; 83(8):2709-13.
      View in: PubMed
    256. Parvin JD, Smith FI, Palese P. Rapid RNA sequencing using double-stranded template DNA, SP6 polymerase, and 3'-deoxynucleotide triphosphates. DNA. 1986 Apr; 5(2):167-71.
      View in: PubMed
    257. Ho YS, Norton GP, Palese P, Dozy AM, Kan YW. Expression and function of suppressor tRNA genes in mammalian cells. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1033-40.
      View in: PubMed
    258. Buonagurio DA, Nakada S, Desselberger U, Krystal M, Palese P. Noncumulative sequence changes in the hemagglutinin genes of influenza C virus isolates. Virology. 1985 Oct 30; 146(2):221-32.
      View in: PubMed
    259. Nakada S, Graves PN, Desselberger U, Creager RS, Krystal M, Palese P. Influenza C virus RNA 7 codes for a nonstructural protein. J Virol. 1985 Oct; 56(1):221-6.
      View in: PubMed
    260. Greenspan D, Krystal M, Nakada S, Arnheiter H, Lyles DS, Palese P. Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. J Virol. 1985 Jun; 54(3):833-43.
      View in: PubMed
    261. Laski FA, Belagaje R, Hudziak RM, Capecchi MR, Norton GP, Palese P, RajBhandary UL, Sharp PA. Synthesis of an ochre suppressor tRNA gene and expression in mammalian cells. EMBO J. 1984 Nov; 3(11):2445-52.
      View in: PubMed
    262. Nakada S, Creager RS, Krystal M, Palese P. Complete nucleotide sequence of the influenza C/California/78 virus nucleoprotein gene. Virus Res. 1984 Sep; 1(6):433-41.
      View in: PubMed
    263. Nakada S, Creager RS, Krystal M, Aaronson RP, Palese P. Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins. J Virol. 1984 Apr; 50(1):118-24.
      View in: PubMed
    264. Townsend AR, Skehel JJ, Taylor PM, Palese P. Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone. Virology. 1984 Mar; 133(2):456-9.
      View in: PubMed
    265. Buonagurio DA, Krystal M, Palese P, DeBorde DC, Maassab HF. Analysis of an influenza A virus mutant with a deletion in the NS segment. J Virol. 1984 Feb; 49(2):418-25.
      View in: PubMed
    266. Young JF, Desselberger U, Palese P, Ferguson B, Shatzman AR, Rosenberg M. Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A. 1983 Oct; 80(19):6105-9.
      View in: PubMed
    267. Young JF, Capecchi M, Laski FA, RajBhandary UL, Sharp PA, Palese P. Measurement of suppressor transfer RNA activity. Science. 1983 Aug 26; 221(4613):873-5.
      View in: PubMed
    268. Parvin JD, Young JF, Palese P. Nonsense mutations affecting the lengths of the NS1 nonstructural proteins of influenza A virus isolates. Virology. 1983 Jul 30; 128(2):512-7.
      View in: PubMed
    269. Krystal M, Young JF, Palese P, Wilson IA, Skehel JJ, Wiley DC. Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A. 1983 Jul; 80(14):4527-31.
      View in: PubMed
    270. Graves PN, Schulman JL, Young JF, Palese P. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology. 1983 Apr 15; 126(1):106-16.
      View in: PubMed
    271. Krystal M, Buonagurio D, Young JF, Palese P. Sequential mutations in the NS genes of influenza virus field strains. J Virol. 1983 Feb; 45(2):547-54.
      View in: PubMed
    272. Krystal M, Elliott RM, Benz EW, Young JF, Palese P. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A. 1982 Aug; 79(15):4800-4.
      View in: PubMed
    273. Palese P, Young JF. Variation of influenza A, B, and C viruses. Science. 1982 Mar 19; 215(4539):1468-74.
      View in: PubMed
    274. Aaronson RP, Young JF, Palese P. Oligonucleotide mapping: evaluation of its sensitivity by computer-simulation. Nucleic Acids Res. 1982 Jan 11; 10(1):237-46.
      View in: PubMed
    275. Mitsialis SA, Young JF, Palese P, Guntaka RV. An avian tumor virus promoter directs expression of plasmid genes in Escherichia coli. Gene. 1981 Dec; 16(1-3):217-25.
      View in: PubMed
    276. Baez M, Zazra JJ, Elliott RM, Young JF, Palese P. Nucleotide sequence of the influenza A/duck/Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 overlapping gene structure in a divergent influenza virus RNA segment. Virology. 1981 Aug; 113(1):397-402.
      View in: PubMed
    277. Baez M, Taussig R, Zazra JJ, Young JF, Palese P, Reisfeld A, Skalka AM. Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res. 1980 Dec 11; 8(23):5845-58.
      View in: PubMed
    278. Brand C, Palese P. Sequential passage of influenza virus in embryonated eggs or tissue culture: emergence of mutants. Virology. 1980 Dec; 107(2):424-33.
      View in: PubMed
    279. Palese P. New biochemical techniques for the characterization of viruses to assist the epidemiologist. J Infect Dis. 1980 Oct; 142(4):633-5.
      View in: PubMed
    280. Lubeck MD, Schulman JL, Palese P. Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology. 1980 Apr 30; 102(2):458-62.
      View in: PubMed
    281. Baez M, Palese P, Kilbourne ED. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis. 1980 Mar; 141(3):362-5.
      View in: PubMed
    282. Palese P, Racaniello VR, Desselberger U, Young J, Baez M. Genetic structure and genetic variation of influenza viruses. Philos Trans R Soc Lond B Biol Sci. 1980 Feb 25; 288(1029):299-305.
      View in: PubMed
    283. Desselberger U, Racaniello VR, Zazra JJ, Palese P. The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene. 1980 Feb; 8(3):315-28.
      View in: PubMed
    284. Palese P, Roizman B. Genetic variation of viruses. Introductory remarks. Ann N Y Acad Sci. 1980; 354:ix.
      View in: PubMed
    285. Young JF, Elliott RM, Berkowitz EM, Palese P. Mechanisms of genetic variation in human influenza viruses. Ann N Y Acad Sci. 1980; 354:135-41.
      View in: PubMed
    286. Racaniello VR, Palese P. Isolation of influenza C virus recombinants. J Virol. 1979 Dec; 32(3):1006-14.
      View in: PubMed
    287. Young JF, Palese P. Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc Natl Acad Sci U S A. 1979 Dec; 76(12):6547-51.
      View in: PubMed
    288. Young JF, Desselberger U, Palese P. Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell. 1979 Sep; 18(1):73-83.
      View in: PubMed
    289. Lubeck MD, Palese P, Schulman JL. Nonrandom association of parental genes in influenza A virus recombinants. Virology. 1979 May; 95(1):269-74.
      View in: PubMed
    290. Racaniello VR, Palese P. Influenza B virus genome: assignment of viral polypeptides to RNA segments. J Virol. 1979 Jan; 29(1):361-73.
      View in: PubMed
    291. Lubeck MD, Schulman JL, Palese P. Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol. 1978 Dec; 28(3):710-6.
      View in: PubMed
    292. Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature. 1978 Jul 27; 274(5669):334-9.
      View in: PubMed
    293. Desselberger U, Palese P. Molecular weights of RNA segments of influenza A and B viruses. Virology. 1978 Jul 15; 88(2):394-9.
      View in: PubMed
    294. Desselberger U, Nakajima K, Alfino P, Pedersen FS, Haseltine WA, Hannoun C, Palese P. Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A. 1978 Jul; 75(7):3341-5.
      View in: PubMed
    295. Moss B, Keith JM, Gershowitz A, Ritchey MB, Palese P. Common sequence at the 5' ends of the segmented RNA genomes of influenza A and B viruses. J Virol. 1978 Jan; 25(1):312-8.
      View in: PubMed
    296. Schulman JL, Palese P. Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol. 1977 Oct; 24(1):170-6.
      View in: PubMed
    297. Palese P, Ritchey MB. Polyacrylamide gel electrophoresis of the RNAs of new influenza virus strains: an epidemiological tool. Dev Biol Stand. 1977 Jun 1-3; 39:411-5.
      View in: PubMed
    298. Palese P, Ritchey MB. Live attenuated influenza virus vaccines. Strains with temperature-sensitive defects in P3 protein and nucleoprotein. Virology. 1977 May 1; 78(1):183-91.
      View in: PubMed
    299. Ritchey MB, Palese P. Identification of the defective genes in three mutant groups of influenza virus. J Virol. 1977 Mar; 21(3):1196-204.
      View in: PubMed
    300. Palese P, Ritchey MB, Schulman JL. P1 and P3 proteins of influenza virus are required for complementary RNA synthesis. J Virol. 1977 Mar; 21(3):1187-95.
      View in: PubMed
    301. Palese P, Ritchey MB, Schulman JL. Mapping of the influenza virus genome. II. Identification of the P1, P2, and P3 genes. Virology. 1977 Jan; 76(1):114-21.
      View in: PubMed
    302. Ritchey MB, Palese P, Schulman JL. Difference in protein patterns of influenza A viruses. Virology. 1977 Jan; 76(1):122-8.
      View in: PubMed
    303. Palese P. The genes of influenza virus. Cell. 1977 Jan; 10(1):1-10.
      View in: PubMed
    304. Palese P, Ritchey MB, Schulman JL, Kilbourne ED. Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza. Science. 1976 Oct 15; 194(4262):334-5.
      View in: PubMed
    305. Palese P, Schulman JL. RNA pattern of 'swine' influenza virus isolated from man is similar to those of other swine influenza viruses. Nature. 1976 Oct 7; 263(5577):528-30.
      View in: PubMed
    306. Palese P, Compans RW. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol. 1976 Oct; 33(1):159-63.
      View in: PubMed
    307. Ritchey MB, Palese P, Schulman JL. Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol. 1976 Oct; 20(1):307-13.
      View in: PubMed
    308. Schulman JL, Palese P. Selection and identification of influenza virus recombinants of defined genetic composition. J Virol. 1976 Oct; 20(1):248-54.
      View in: PubMed
    309. Richey MB, Palese P. In vitro translation of influenza virus messenger RNAs. Virology. 1976 Jul 15; 72(2):410-20.
      View in: PubMed
    310. Palese P, Schulman JL. Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A. 1976 Jun; 73(6):2142-6.
      View in: PubMed
    311. Ritchey MB, Palese P, Kilbourne ED. RNAs of influenza A, B, and C viruses. J Virol. 1976 May; 18(2):738-44.
      View in: PubMed
    312. Palese P, Schulman JL. Differences in RNA patterns of influenza A viruses. J Virol. 1976 Mar; 17(3):876-84.
      View in: PubMed
    313. Krug RM, Ueda M, Palese P. Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol. 1975 Oct; 16(4):790-6.
      View in: PubMed
    314. Schulman JL, Palese P. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA). Virology. 1975 Jan; 63(1):98-104.
      View in: PubMed
    315. Palese P, Tobita K, Ueda M, Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology. 1974 Oct; 61(2):397-410.
      View in: PubMed
    316. Palese P, Schulman JL, Bodo G, Meindl P. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology. 1974 Jun; 59(2):490-8.
      View in: PubMed
    317. Meindl P, Bodo G, Palese P, Schulman J, Tuppy H. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology. 1974 Apr; 58(2):457-63.
      View in: PubMed
    318. Palese P, Schulman J. Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations. Virology. 1974 Jan; 57(1):227-37.
      View in: PubMed
    319. Compans RW, Meier-Ewert H, Palese P. Assembly of lipid-containing viruses. J Supramol Struct. 1974; 2(2-4):496-511.
      View in: PubMed
    320. Palese P, Bucher D, Kilbourne ED. Applications of a synthetic neuraminidase substrate. Appl Microbiol. 1973 Feb; 25(2):195-201.
      View in: PubMed
    321. Palese P, McAuslan BR. Virus-associated DNase: endonuclease in a polyhedral cytoplasmic deoxyvirus. Virology. 1972 Jul; 49(1):319-21.
      View in: PubMed
    322. Palese P, Koch G. Degradation of single- and double-stranded RNA by frog virus 3. Proc Natl Acad Sci U S A. 1972 Mar; 69(3):698-701.
      View in: PubMed
    323. Aubertin A, Palese P, Tan KB, Vilagines R, McAuslan BR. Proteins of a polyhedral cytoplasmic deoxyvirus. 3. Structure of frog virus 3 and location ov virus-associated adenosine triphosphate phosphohydrolase. J Virol. 1971 Nov; 8(5):643-8.
      View in: PubMed
    324. Bodo G, Palese P, Lindner J. Activity of mouse interferon in human cells. Proc Soc Exp Biol Med. 1971 Sep; 137(4):1392-5.
      View in: PubMed
    325. Meindl P, Bodo G, Lindner J, Palese P. [Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus]. Z Naturforsch B. 1971 Aug; 26(8):792-7.
      View in: PubMed
    326. Bodo G, Palese P, Horak I, Hilfenhaus J, Siegert W, Jungwirth C. Interferon action: effect on the formation of poxvirus specific polysomes and viral RNA. Z Naturforsch B. 1970 Oct; 25(10):1164-70.
      View in: PubMed
    327. Palese P, Bodo G, Tuppy H. Quantitative determination of neuraminidase-active foci in cell monolayer cultures infected with influenza or newcastle disease virus. J Virol. 1970 Oct; 6(4):556-8.
      View in: PubMed
    328. Tuppy H, Palese P. [Pig kidney neuraminidase: purification and properties]. Hoppe Seylers Z Physiol Chem. 1968 Sep; 349(9):1169-78.
      View in: PubMed
    Palese's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067